These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 16361550)
1. Inclusion of vasculature-related variables in the Dukes staging system of colon cancer. Koukourakis MI; Giatromanolaki A; Sivridis E; Gatter KC; Harris AL; Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8653-60. PubMed ID: 16361550 [TBL] [Abstract][Full Text] [Related]
2. Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer. Wang Y; Jatkoe T; Zhang Y; Mutch MG; Talantov D; Jiang J; McLeod HL; Atkins D J Clin Oncol; 2004 May; 22(9):1564-71. PubMed ID: 15051756 [TBL] [Abstract][Full Text] [Related]
3. Differential assessment of vascular survival ability and tumor angiogenic activity in colorectal cancer. Giatromanolaki A; Sivridis E; Minopoulos G; Polychronidis A; Manolas C; Simopoulos C; Koukourakis MI Clin Cancer Res; 2002 May; 8(5):1185-91. PubMed ID: 12006536 [TBL] [Abstract][Full Text] [Related]
4. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil. Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C Oncology; 2006; 70(5):366-77. PubMed ID: 17179731 [TBL] [Abstract][Full Text] [Related]
5. Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group. Dahl O; Fluge Ø; Carlsen E; Wiig JN; Myrvold HE; Vonen B; Podhorny N; Bjerkeset O; Eide TJ; Halvorsen TB; Tveit KM; Acta Oncol; 2009; 48(3):368-76. PubMed ID: 19242829 [TBL] [Abstract][Full Text] [Related]
6. Cancer invasion to Auerbach's plexus is an important prognostic factor in patients with pT3-pT4 colorectal cancer. Fujita S; Nakanisi Y; Taniguchi H; Yamamoto S; Akasu T; Moriya Y; Shimoda T Dis Colon Rectum; 2007 Nov; 50(11):1860-6. PubMed ID: 17899273 [TBL] [Abstract][Full Text] [Related]
7. [Adjuvant chemotherapy for colon cancer]. Dahl O Tidsskr Nor Laegeforen; 2007 Nov; 127(23):3094-6. PubMed ID: 18049502 [TBL] [Abstract][Full Text] [Related]
8. [Lymph node micrometastases and expression of metastasis-related gene proteins in patients with colorectal cancer]. Fan YZ; Li XP; Liu WF; Li GM Zhonghua Wai Ke Za Zhi; 2006 Feb; 44(3):181-5. PubMed ID: 16635348 [TBL] [Abstract][Full Text] [Related]
9. [Surgical therapy of colon carcinoma with local invasion: a useful treatment?]. Kroneman H; Jeekel J Ned Tijdschr Geneeskd; 1989 Dec; 133(48):2396-8. PubMed ID: 2479846 [TBL] [Abstract][Full Text] [Related]
10. Molecular staging for survival prediction of colorectal cancer patients. Eschrich S; Yang I; Bloom G; Kwong KY; Boulware D; Cantor A; Coppola D; Kruhøffer M; Aaltonen L; Orntoft TF; Quackenbush J; Yeatman TJ J Clin Oncol; 2005 May; 23(15):3526-35. PubMed ID: 15908663 [TBL] [Abstract][Full Text] [Related]
11. Indication and efficacy of adjuvant chemotherapy with oral fluoropyrimidines for dukes' B colorectal cancer. Yoshimatsu K; Umehara A; Ishibashi K; Yokomizo H; Yoshida K; Fujimoto T; Watanabe K; Ogawa K Anticancer Res; 2006; 26(4B):3089-93. PubMed ID: 16886639 [TBL] [Abstract][Full Text] [Related]
12. Identification of serosal invasion and extramural venous invasion on review of Dukes' stage B colonic carcinomas and correlation with survival. Stewart CJ; Morris M; de Boer B; Iacopetta B Histopathology; 2007 Sep; 51(3):372-8. PubMed ID: 17727478 [TBL] [Abstract][Full Text] [Related]
13. Identification of patients with high-risk stage II colon cancer for adjuvant therapy. Quah HM; Chou JF; Gonen M; Shia J; Schrag D; Landmann RG; Guillem JG; Paty PB; Temple LK; Wong WD; Weiser MR Dis Colon Rectum; 2008 May; 51(5):503-7. PubMed ID: 18322753 [TBL] [Abstract][Full Text] [Related]
14. American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinoma. Rizk NP; Venkatraman E; Bains MS; Park B; Flores R; Tang L; Ilson DH; Minsky BD; Rusch VW; J Clin Oncol; 2007 Feb; 25(5):507-12. PubMed ID: 17290058 [TBL] [Abstract][Full Text] [Related]
15. [Pelvic lymphadenectomy as an alternative to adjuvant radiotherapy in early stage endometrial cancer at high risk of recurrent lymphatic metastases (stage I)]. Amato NA; Partipilo V; Mele F; Boscia F; De Marzo P Minerva Ginecol; 2009 Feb; 61(1):1-12. PubMed ID: 19204656 [TBL] [Abstract][Full Text] [Related]
16. Pre-operative immunoprophylaxis with interleukin-2 may improve prognosis in radical surgery for colorectal cancer stage B-C. Brivio F; Fumagalli L; Lissoni P; Nardone A; Nespoli L; Fattori L; Denova M; Chiarelli M; Nespoli A Anticancer Res; 2006; 26(1B):599-603. PubMed ID: 16739327 [TBL] [Abstract][Full Text] [Related]
17. A Dukes/Jass combination--is it more discriminating? Haslam AC; Pearson JM; Bisset DL; Michie HR; Hobbiss JH Colorectal Dis; 2006 Jun; 8(5):418-22. PubMed ID: 16684086 [TBL] [Abstract][Full Text] [Related]
18. Elevated preoperative serum carcinoembrionic antigen level may be an effective indicator for needing adjuvant chemotherapy after potentially curative resection of stage II colon cancer. Ogata Y; Murakami H; Sasatomi T; Ishibashi N; Mori S; Ushijima M; Akagi Y; Shirouzu K J Surg Oncol; 2009 Jan; 99(1):65-70. PubMed ID: 18942720 [TBL] [Abstract][Full Text] [Related]
19. [Meta-analysis of postoperative adjuvant chemotherapy for Dukes' B colorectal carcinoma]. Wan XB; Pan ZZ; Chen G; Li LR; Wan DS Ai Zheng; 2005 May; 24(5):600-4. PubMed ID: 15890106 [TBL] [Abstract][Full Text] [Related]
20. Prognostic indicators for stage II (Dukes' stage B) adenocarcinoma of the colon. Asaad SM; Jubelirer SJ; Welch CA W V Med J; 2005; 101(5):210-3. PubMed ID: 16422269 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]